Division of Genetics, Department of Medicine, Brigham and Women's Hospital, Boston, United States; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, United States; Department of Pharmacology and Molecular Sciences, Johns Hopkins School of Medicine, Baltimore, United States
Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, United States; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, United States
Division of Genetics, Department of Medicine, Brigham and Women's Hospital, Boston, United States; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, United States
Antonieta Salguero
Division of Genetics, Department of Medicine, Brigham and Women's Hospital, Boston, United States; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, United States; Department of Pharmacology and Molecular Sciences, Johns Hopkins School of Medicine, Baltimore, United States
Andras Boeszoermenyi
Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, United States; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, United States
Haribabu Arthanari
Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, United States; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, United States
Division of Genetics, Department of Medicine, Brigham and Women's Hospital, Boston, United States; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, United States; Department of Pharmacology and Molecular Sciences, Johns Hopkins School of Medicine, Baltimore, United States
Akt is a critical protein kinase that governs cancer cell growth and metabolism. Akt appears to be autoinhibited by an intramolecular interaction between its N-terminal pleckstrin homology (PH) domain and kinase domain, which is relieved by C-tail phosphorylation, but the precise molecular mechanisms remain elusive. Here, we use a combination of protein semisynthesis, NMR, and enzymological analysis to characterize structural features of the PH domain in its autoinhibited and activated states. We find that Akt autoinhibition depends on the length/flexibility of the PH-kinase linker. We identify a role for a dynamic short segment in the PH domain that appears to regulate autoinhibition and PDK1-catalyzed phosphorylation of Thr308 in the activation loop. We determine that Akt allosteric inhibitor MK2206 drives distinct PH domain structural changes compared to baseline autoinhibited Akt. These results highlight how the conformational plasticity of Akt governs the delicate control of its catalytic properties.